The company provides specialized software solutions and IT infrastructure services, primarily focusing on healthcare management systems, pharmaceutical distribution platforms, and e-governance projects for government and corporate clients in India and the Middle East.
While the company claims a moat through domain expertise in healthcare and pharma, the financials show a revenue CAGR of -1.1% and a shift from profit to significant losses. The mechanism of switching costs is not corroborated by the numbers, as margins have compressed and cash conversion is poor at 0.20.
Management has pivoted toward internal product development (PharmaZip, HospyCare) and international expansion into the UAE, but these investments have yet to generate positive returns, resulting in a transition to net losses and negative interest coverage.
The company's pivot into proprietary software products and UAE expansion failed to gain traction, further draining cash reserves while the core business stagnated. The inability to collect long-overdue receivables from international clients led to a liquidity crunch, exacerbated by the loss of institutional trust following the auditor's resignation. As internal controls crumbled and physical assets remained unverified, the business transitioned from a mediocre service provider to a loss-making entity with no path back to profitability, eventually resulting in a total impairment of intangible assets.
RichFakir rates Micropro Software Solutions Ltd's business quality as poor — 15/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Micropro Software Solutions Ltd is trading about 76% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Micropro Software Solutions Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Micropro Software Solutions Ltd's fair value is about ₹10 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →